128 related articles for article (PubMed ID: 15922902)
1. Preoperative evaluation and methods to reduce blood use in orthopedic surgery.
Keating EM
Anesthesiol Clin North Am; 2005 Jun; 23(2):305-13, vi-vii. PubMed ID: 15922902
[TBL] [Abstract][Full Text] [Related]
2. Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin.
Price TH; Goodnough LT; Vogler WR; Sacher RA; Hellman RM; Johnston MF; Bolgiano DC; Abels RI
Am J Med; 1996 Aug; 101(2A):22S-27S. PubMed ID: 8928704
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative strategy for homologous blood salvage and peri-operative erythropoietin].
Rosencher N; Woimant G; Ozier Y; Conseiller C
Transfus Clin Biol; 1999 Dec; 6(6):370-9. PubMed ID: 10666795
[TBL] [Abstract][Full Text] [Related]
4. Epoetin alfa plus autologous blood donation and normovolemic hemodilution in patients scheduled for orthopedic or vascular surgery.
Tryba M
Semin Hematol; 1996 Apr; 33(2 Suppl 2):34-6; discussion 37-8. PubMed ID: 8723580
[TBL] [Abstract][Full Text] [Related]
5. [Erythropoietin alone or as an adjuvant for the autologous blood donation program in major orthopedic surgery].
Bisbe E; Sáez M; Nomen N; Castillo J; Santiveri X; Mestre C; Cano X
Rev Esp Anestesiol Reanim; 2003 Oct; 50(8):395-400. PubMed ID: 14601367
[TBL] [Abstract][Full Text] [Related]
6. Perioperative blood management practices in elective orthopaedic surgery.
Keating EM; Meding JB
J Am Acad Orthop Surg; 2002; 10(6):393-400. PubMed ID: 12470041
[TBL] [Abstract][Full Text] [Related]
7. Enhanced efficacy of autologous blood donation with epoetin alfa.
Nydegger U
Semin Hematol; 1996 Apr; 33(2 Suppl 2):39-40; discussion 41-2. PubMed ID: 8723581
[TBL] [Abstract][Full Text] [Related]
8. Autologous versus allogeneic transfusion: patients' perceptions and experiences.
Graham ID; Fergusson D; Dokainish H; Biggs J; McAuley L; Laupacis A
CMAJ; 1999 Apr; 160(7):989-95. PubMed ID: 10207337
[TBL] [Abstract][Full Text] [Related]
9. Strategies for minimizing the use of allogeneic blood during orthopedic surgery.
Rosenblatt MA
Mt Sinai J Med; 2002; 69(1-2):83-7. PubMed ID: 11832977
[TBL] [Abstract][Full Text] [Related]
10. Epoetin alfa as an adjunct to autologous blood donation in patients with a low hematocrit scheduled for elective orthopedic surgery.
Adamson J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):15-6; discussion 17. PubMed ID: 8723575
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
Stovall TG
J Reprod Med; 2001 May; 46(5 Suppl):531-8. PubMed ID: 11396387
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donation.
Wurnig C; Schatz K; Noske H; Hemon Y; Dahlberg G; Josefsson G; Milbrink J; Hamard C;
Eur Surg Res; 2001; 33(5-6):303-10. PubMed ID: 11805389
[TBL] [Abstract][Full Text] [Related]
13. Perisurgical use of epoetin alfa in orthopedic surgery patients.
Adamson J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):55-8; discussion 59. PubMed ID: 8723584
[TBL] [Abstract][Full Text] [Related]
14. Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: a randomized, double-blind, placebo-controlled, dose-ranging study.
Mercuriali F; Inghilleri G; Biffi E; Colotti MT; Vinci A; Oriani G
Acta Haematol; 1998; 100(2):69-76. PubMed ID: 9792935
[TBL] [Abstract][Full Text] [Related]
15. Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction.
Lofthouse RA; Boitano MA; Davis JR; Jinnah RH
J South Orthop Assoc; 2000; 9(3):175-81. PubMed ID: 12135299
[TBL] [Abstract][Full Text] [Related]
16. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302
[TBL] [Abstract][Full Text] [Related]
17. Epoetin alfa. A bloodless approach for the treatment of perioperative anemia.
Faris PM; Ritter MA
Clin Orthop Relat Res; 1998 Dec; (357):60-7. PubMed ID: 9917701
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of preoperative anemia in major orthopedic surgery].
Bisbe Vives E
Rev Esp Anestesiol Reanim; 2015 Jun; 62 Suppl 1():52-6. PubMed ID: 26320345
[TBL] [Abstract][Full Text] [Related]
19. Minimizing transfusion requirements for children undergoing craniosynostosis repair: the CHoR protocol.
Vega RA; Lyon C; Kierce JF; Tye GW; Ritter AM; Rhodes JL
J Neurosurg Pediatr; 2014 Aug; 14(2):190-5. PubMed ID: 24877603
[TBL] [Abstract][Full Text] [Related]
20. Epoetin alfa as an adjuvant to autologous blood donation.
Beris P
Semin Hematol; 1996 Apr; 33(2 Suppl 2):27-9; discussion 30. PubMed ID: 8723578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
